Blog Posts in March, 2006

  • H&R Block Allegedly Defrauded Clients with Express IRA’s

    Lawsuits have recently been filed against H&R Block alleging that the tax preparer’s “Express” IRA’s costs more in fees that they generate in interest. The suit further alleged that about 500,000 people purchased the IRA, seeking damages in upwards of $250 million in penalties and compensation. Read more here .
    Continue Reading
  • Illinois Dept. of Financial Regulation Orders Malpractice Insurer to Reduce Rates

    In the wake of the medical malpractice bill passed by the General Assembly last summer, Illinois largest medical malpractice insurer, ISMIE, was recently ordered to reduce rates charged to Illinois doctors. The medical malpractice reform law capped awards on non-economic damages, but also implemented new insurance regulation. As a result of these new regulations, ISMIE was subject to hearings ...
    Continue Reading
  • $9 Auto Fuel Tank Safety Improvement Could Have Saved Family From Burns

    In 1993, Patricia Anderson and her four children were rear ended in their Chevy Malibu. The impact caused the fuel tank to leak, and the gas ignited setting the car ablaze. Everyone in the car was seriously burned, with 3 of the 4 children sustaining burns over 60% of their body. The subsequent lawsuit revealed that the fuel tank design on the car was unreasonably dangerous. GM could have designed ...
    Continue Reading
  • Companies Held Responsible for Lead Paint Injuries

    Motley Rice, a powerhouse for plaintiff’s rights and one of our co-counsel, recently added victims of lead paint poisioning to its list of victories. Last month, a Rhode Island state court jury found that peeling lead paint constitutes a public nuisance: an inherently dangerous condition that attracts young children to touch and possible ingest. After nearly 20 years of dodging plaintiffs’ ...
    Continue Reading
  • Drug Companies Fail to Carry Through on Post Marketing Safety Trials

    In an effort to speed up the drug approval process, the FDA allows companies to perform safety studies after the drug has been approved and is on the market. However, many promised studies are never performed. A recent NY Times articles uncovered that hundreds of these studies have been pending for years, with no follow up by the drug companies. The problem is that there is little incentive to ...
    Continue Reading
  • Insurance Company’s “Concerted Effort to Cheat People”

    An engineering company altered a report to eliminate the significant role wind played in severely damaging the home of an elderly Gulfport couple during Hurricane Katrina, according to a lawsuit filed Friday in Mississippi. A Mississippi lawfirm is asking a judge to order the original report restored and award $5 million in damages to Hubert W. and Joyce Smith, who used retirement savings to ...
    Continue Reading
  • Medical Malpractice Insurance “Crisis” Is Over

    Americans for Insurance Reform (AIF) recently released results of a study indicating that malpractice insurance rates have stopped rising. The study, performed by the Council of Insurance Agents and Brokers , indicated that the average rate hike for doctors over the last 6 months was 0 percent. The most important result of this study is that the static rates occurred in both states with and ...
    Continue Reading
  • Preventable Medical Error Causes Four-Year-Old’s Death

    An error during a common surgery aimed to reduce ear infections resulted in the death of four-year-old Harry Donnelly. While doctors were implanting ear tubes and removing his adenoids, his breathing tube became dislodged. The oxygen monitor had slipped off Harry’s pinky finger, and no warning sounds went off. As a result, Harry went without oxygen for 36 minutes and ultimately died. The Institute ...
    Continue Reading
  • Protections From Accutane Related Birth Defects a Failure

    “The government-approved system for preventing pregnant women from taking Accutane, the acne drug linked to miscarriages and severe birth defects, is a ‘disaster,’ the nation’s leading dermatology association told a federal advisory panel on Friday. ‘Pharmacies, prescribers and patients are confused and frustrated,’ said Dr. Diane M. Thiboutot of the American Academy of Dermatology, who held a ...
    Continue Reading
  • Zicam Cold Remedy Settlement

    “The manufacturer of Zicam Cold Remedy has agreed to pay $12 million to settle 340 lawsuits brought by consumers who claim the popular over-the-counter zinc nasal gel damaged or destroyed their sense of smell. The Phoenix-based manufacturer, Matrixx Initatives, says the agreement announced Jan. 19 is not an admission of liability, but rather an effort to end most of the litigation over the ...
    Continue Reading
  • Failure Rate of Guidant Defibrillators Doubled

    “Medical device maker Guidant (GDT) said Monday that the failure rate from a faulty hermetic seal in some of its recalled pacemakers has increased from summer projections. The company, based in Indianapolis, told doctors that 145 cases have been reported of 16,000 pacemakers that remain implanted in patients’ chests, raising the failure rate from July’s range of 0.17 to 0.51 to a new range of 0.31 ...
    Continue Reading
  • FDA Looks To Shield Drug Makers From Liability

    “The U.S. Food and Drug Administration, though it has improved a drug labeling regulation through revisions announced today, continues to ignore the fact that its rule will not guarantee patients the most accurate, up-to-date information about their medications, Public Citizen said today. Further, in an end-run around Congress, the FDA has added to the rule a preamble designed to preempt lawsuits ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.